ATE180168T1 - Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus - Google Patents

Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus

Info

Publication number
ATE180168T1
ATE180168T1 AT93922725T AT93922725T ATE180168T1 AT E180168 T1 ATE180168 T1 AT E180168T1 AT 93922725 T AT93922725 T AT 93922725T AT 93922725 T AT93922725 T AT 93922725T AT E180168 T1 ATE180168 T1 AT E180168T1
Authority
AT
Austria
Prior art keywords
diabetes mellitus
dependent diabetes
prevent insulin
insulin
prevent
Prior art date
Application number
AT93922725T
Other languages
English (en)
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paul J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE180168T1 publication Critical patent/ATE180168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT93922725T 1992-10-01 1993-09-28 Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus ATE180168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01

Publications (1)

Publication Number Publication Date
ATE180168T1 true ATE180168T1 (de) 1999-06-15

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93922725T ATE180168T1 (de) 1992-10-01 1993-09-28 Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus

Country Status (23)

Country Link
EP (1) EP0662837B1 (de)
JP (1) JP2739770B2 (de)
KR (1) KR0166663B1 (de)
CN (1) CN1093598A (de)
AT (1) ATE180168T1 (de)
AU (1) AU689448B2 (de)
CA (1) CA2145863A1 (de)
CZ (1) CZ286866B6 (de)
DE (1) DE69325029T2 (de)
DK (1) DK0662837T3 (de)
ES (1) ES2131122T3 (de)
FI (1) FI951511A0 (de)
GR (1) GR3030269T3 (de)
HU (1) HU217871B (de)
IL (1) IL107153A (de)
MX (1) MX9306043A (de)
MY (1) MY111543A (de)
NO (1) NO951240L (de)
SG (1) SG48733A1 (de)
SK (1) SK281806B6 (de)
TW (1) TW336172B (de)
WO (1) WO1994008606A1 (de)
ZA (1) ZA937244B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695883B2 (en) * 1994-04-08 1998-08-27 Brigham And Women's Hospital Treatment of autoimmune disease using oral tolerization and/or Th2-enhancing cytokines
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
DE69534265T2 (de) * 1994-12-12 2006-05-04 Beth Israel Deaconess Medical Center, Inc., Boston Chimäre zytokine und ihre verwendung
JPH11510185A (ja) * 1995-08-07 1999-09-07 シェーリング コーポレイション インターロイキン−１０を用いた眼の炎症性状態の処置
CA2228379A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
ATE293603T1 (de) * 1997-10-14 2005-05-15 Mitsubishi Pharma Corp Piperazin-verbindungen und ihre medizinische verwendung
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
JP6403062B2 (ja) * 2012-12-21 2018-10-10 国立大学法人徳島大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
US11510966B2 (en) 2016-04-15 2022-11-29 Evive Biotechnology (Shanghai) Ltd Use of IL-22 in treating necrotizing enterocolitis
EP4106794A4 (de) 2020-02-19 2024-03-20 Evive Biotechnology (Shanghai) Ltd Verfahren zum behandeln der transplant-und-wirts-krankheit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
SG48733A1 (en) 1998-05-18
MY111543A (en) 2000-08-30
FI951511L (fi) 1995-03-30
HK1008812A1 (en) 1999-05-21
IL107153A (en) 2000-07-16
NO951240D0 (no) 1995-03-30
SK42395A3 (en) 1997-01-08
AU5163593A (en) 1994-05-09
DE69325029T2 (de) 1999-10-07
CZ286866B6 (en) 2000-07-12
GR3030269T3 (en) 1999-08-31
DE69325029D1 (de) 1999-06-24
HU9500933D0 (en) 1995-05-29
HUT71421A (en) 1995-11-28
HU217871B (hu) 2000-04-28
CN1093598A (zh) 1994-10-19
AU689448B2 (en) 1998-04-02
SK281806B6 (sk) 2001-08-06
ZA937244B (en) 1994-06-27
KR0166663B1 (en) 1999-01-15
TW336172B (en) 1998-07-11
DK0662837T3 (da) 1999-11-08
CZ80495A3 (en) 1996-01-17
FI951511A7 (fi) 1995-03-30
EP0662837B1 (de) 1999-05-19
EP0662837A1 (de) 1995-07-19
CA2145863A1 (en) 1994-04-28
FI951511A0 (fi) 1995-03-30
NO951240L (no) 1995-05-30
IL107153A0 (en) 1993-12-28
MX9306043A (es) 1994-04-29
JP2739770B2 (ja) 1998-04-15
ES2131122T3 (es) 1999-07-16
KR950703353A (ko) 1995-09-20
JPH07507567A (ja) 1995-08-24
WO1994008606A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
DE69325029D1 (de) Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus
DE69211406D1 (de) Verwendung von Rapamycin zur Behandlung des Diabetes
DE69428357D1 (de) Vorrichtung zur behandlung des diabetes mellitus
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
YU39595A (sh) Dobijanje kristala stabilnog cinka insulinskog analoga
DE69133397D1 (de) Benzoylderivate
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
AU5699494A (en) Novel liquid phenolic antioxidants
DE69123178D1 (de) Verwendung von Uridin zur pharmakologischen Behandlung der peripheren Komplikationen bei Diabetes
ATE93721T1 (de) Verwendung von fluoxetin zur behandlung des diabetes.
DE3880075D1 (de) Vorrichtung zur kompensation der verzerrung gekruemmter transparenter flaechen.
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
KR950700738A (ko) 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes)
BG44708A3 (bg) Метод за получаване на спиро-3-хетероазолони
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE69103294D1 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE55265T1 (de) Vorrichtung zur behandlung von schrammen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee